METTL3 and hepatocellular carcinoma: Furthermore, the reintroduction of ANLN in METTL3/YTHDF1 knockdown HCC cells restored BM capabilities in vivo (Fig. 3A) along with osteoclast differentiation (Fig. 3B-D).